A kind of shRNA that inhibits the expression of hsa_circ_0001610 and its expression vector
A carrier and DNA sequence technology, applied in the field of molecular biology, can solve the problems of limited target sequence, shRNA knockdown efficiency, target gene expression before and after knockdown, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Example 1 Construction of shRNA expression vector
[0030] The circular RNA information is as follows:
[0031] Name: hsa_circ_0001610
[0032] Coordinates: chr6: 47251673-47254331
[0033] Genbank ID: NM_014452
[0034] Length: 1147nt
[0035] Sequence (SEQ ID NO. 1):
[0036]
[0037] Prepare the shRNA expression vector according to the following steps.
[0038] 1. Oligonucleotide Preparation
[0039] According to the circularization site, primers are designed manually as follows:
[0040] Forward primer (Primer F, SEQ ID NO. 2): CCGG GCCATGCTTGGATTCCTTA CTCGAGTAAGGAATCCAAGCATGGCTTTTT
[0041] Reverse primer (Primer R, SEQ ID NO. 3): AATTAAAAAGCCATGCTTGGATTCCTTACTCGAGTAAGGAATCCAAGCATGGC
[0042] The underlined part (SEQ ID NO. 4) is the target sequence, that is, the part identical to the hsa_circ_0001610 sequence, and the second GC (bold in italics) of this part is the cyclization site.
[0043] The primers were formulated according to the following syst...
Embodiment 2
[0073] Example 2 pLKO.1 sh-0001610 knockdown efficiency verification
[0074] The pLKO.1 sh-0001610 was transferred into A549 cells and RKO cells, respectively, and the expression level of hsa_circ_0001610 (ie, CircTNFRSF21) was detected by qPCR. A vector carrying random sequences (sh-scramble) was used as a control and was also transformed into A549 cells and RKO cells, respectively.
[0075] It can be seen that the expression of hsa_circ_0001610 in the cells transformed into pLKO.1 sh-0001610 is much lower than that of the cells transformed into sh-scramble ( image 3 )
[0076] The results showed that hsa_circ_0001610 was effectively inhibited by pLKO.1 sh-0001610, and the shRNA and its vector that inhibited hsa_circ_0001610 were successfully constructed in the present invention.
[0077] In conclusion, the shRNA and its vector of the present invention can efficiently inhibit the expression of hsa_circ_0001610.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com